136.93 - 143.12
105.43 - 192.79
Join Discuss about SGEN with like-minded investors
Friday, October 29, 2021 Futures Up/Down % Last Dow -45.00 0.13% 35,568 S&P 500 -22.25 0.49% 4,565 Nasdaq -139.50 0.88% 15,625 After trading to all-time highs Thursday for the S&P 500, Dow Jones, and Nasdaq Composite (and a 2% gain for the Russell 2000 as well) on strong earnings as well as positive developments on the spending bill in Washington, futures are pulling back. Shares of tech and retail giants Apple (AAPL) and Amazon (AMZN) are lower by 3% and 4% respectively after AAPL’s iPhone and overall revs miss for the quarter and AMZN drops on a Q3 revs miss, lower op income and lower guidance, sending Nasdaq Futures lower by about 1%. Investor sentiment is also starting to turn cautious amid the steady stream of corporate warnings on inflationary pressures and supply chain woes. Big day of inflation data with the personal spending and income for Sept and PCE inflation data expected at 8:30 AM. The 10-year Treasury yield is up around 1.61%, recovering off mid-week lows around the mid 1.5% level. Bitcoin prices are lower holding around the $60K level while oil futures are on track to snap their 8-week winning streak. In Asian markets, The Nikkei Index rises 0.25% to 28,890, the Shanghai Index gains 0.8% to 3,547, and the Hang Seng Index falls =0.7% to 25,377. In Europe, the German DAX is lower -1.2% to 15,500, while the FTSE 100 down -0.5% at 7,210. Market Closing Prices Yesterday The S&P 500 Index gained 44.74 points, or 0.98%, to 4,596.42 The Dow Jones Industrial Average rose 239.79 points, or 0.68%, to 35,730.48 The Nasdaq Composite surged 212.28 points, or 1.39%, to 15,448.12 The Russell 2000 Index advanced 45.49 points, or 2.02% to 2,297.98 Events Calendar for Today 8:30 AM ET Personal Income for September…est. (-0.2%) 8:30 AM ET Personal Spending for September…prior +0.4% 8:30 AM ET PCE Price Index MoM for September 8:30 AM ET PCE Price Index YoY for September 8:30 AM ET Core PCE Price Index MoM for September…est. +0.2% 8:30 AM ET Core PCE Price Index YoY for September…est. +3.7% 9:45 AM ET Chicago PMI for October…est. 63.5 (prior 64.7) 10:00 AM ET University of Michigan Confidence, Oct-F…est. 71.4 1:00 PM EST Baker Hughes Weekly rig count data Earnings Calendar: Earnings Before the Open: ABBV, AON, B, BAH, CERN, CHD, CHTR, CL, COWN, CVX, DCOM, HUN, IRMD, LHX, PIPR, POR, PSX, PSXP, RUTH, WY, XOM Macro Up/Down Last Nymex 0.34 83.15 Brent 0.37 84.69 Gold -2.95 1,795.95 EUR/USD -0.0029 1.1652 JPY/USD 0.19 113.76 10-Year Note +0.041 1.61% Sector News Breakdown Consumer com (AMZN) shares fall -3%; 3Q EPS $6.12 vs est. $8.92 on sales $110.8B vs est. $111.6B, AWS net sales $16.11B; guides 4Q sales $130-140B vs est. $142B; sees q4 operating income is expected to be between $0 and $3.0 bln, compared with $6.9 bln in q4 2020; in q4, expect to incur several bln dollars of additional costs in consumer business as we manage through labor supply shortages Starbucks (SBUX) Q4 EPS $1.00 vs. est. $0.99; Q4 revs rose 31% to $8.1B vs. est. $8.21B; commits to $20 bln of share repurchases and dividends over next three years; qtrly active Starbucks rewards membership in U.S. approaches 25 mln, up 28% YoY; qtrly comp store sales of 17% globally; qtrly international comp store sales grew 3%; qtrly comp store sales of 22% in U.S.; comp store sales decreased 7% in China Columbia Sportswear (COLM) 3Q EPS $1.52 vs est. $1.33 on revs $804.7Mm vs est. $862Mm; qtrly inventory -7%; guides FY net sales +21.5-23% vs prior +25-26.5% and est. +26.5%, sees FY EPS $4.55-4.80 vs est. $4.65; says believe can achieve mid-teens or better net sales growth in 2022 vs est. +10% Decker’s Outdoors (DECK) 2Q EPS $3.66 vs est. $4.00 on sales $721.9Mm vs est. $765.9Mm, comps +1%; sees FY EPS $14.15-15.15 vs est. $15.15; Gross margin was 50.9% compared to 51.2% for the same period last year; Decker’s also said: UGG(R) brand net sales for the second quarter increased 8.0% to $448.4 million compared to $415.1 million for the same period last year. HOKA(R) brand net sales for the second quarter increased 47.0% to $210.4 million compared to $143.1 million for the same period last year. Teva(R) brand net sales for the second quarter increased 4.0% to $28.8 million compared to $27.7 million for the same period last year. Frontdoor (FTDR) 3Q EPS $0.89 vs est. $0.68 on revs $471Mm vs est. $476.5Mm; guides 4Q revs $330-340Mm vs est. $347.7Mm, sees FY revs $1.59-1.6B vs est. $1.62B Mohawk Industries (MHK) Q3 adj EPS $3.95 vs. est. $3.81; Q3 revs $2.817B vs. est. $2.9B; guides Q4 EPS $2.80-$2.90 vs. est. $3.23 Skecher’s (SKX) Q3 EPS $0.66 vs. est. $0.73; Q3 sales rose 19.2% to $1.55B vs. est. $1.63B; guides Q4 EPS $0.28-$0.33 vs. est. $0.34 and year EPS view cut to $2.45-$2.50 from $2.55-$2.65; cuts FY21 revenue view to $6.15B-$6.2B from $6.15B-$6.25B; Direct-to-Consumer sales grew 44.1% and wholesale sales grew 10.5% SkyWest (SKYW) 3Q adj EPS $1.45 vs est. $0.70 on revs $745Mm vs est. $687.7Mm; says experienced a severe outage in October resulting in about 1,700 flight cancelations and expect may impact 4Q results from $15-20Mm pre-tax; Texas Roadhouse (TXRH) Q3 EPS $0.75 vs est. $0.81 on revenue $869.9M vs est. $869.4M; comp sales +30.2% vs 3Q20, +22.3% vs 2019, partially offset by higher food/beverage costs with commodity inflation 13.9% driven by higher beef prices; sees positive comp sales in FY22, commodity cost inflation in high-teens in 1H22 Energy Chevron (CVX) Q3 adj EPS $2.96 vs. est. $2.21; Q3 revs $43B vs. est. $40.52B; posted net income of $6.11B vs. a loss of $207M a year ago; said Q3 average sales price per barrel of crude oil and natural gas liquids was $58, vs $31 a year earlier Dril-Quip (DRQ) 3Q EPS ($0.31) vs est. ($0.14) on revs $83Mm vs est. $85.6Mm, sees 4Q bookings at high end of $40-60Mm range (unchanged from prior view) First Energy (FE) Q3 adj EPS $0.82 vs. est. $0.79; Q3 revs $3.1B in-line with ests; raises FY21 adj EPS view to $2.55-$2.65 from $2.40-$2.60 (est. $2.54) SM Energy (SM) Q3 EPS $0.69 vs. est. $0.13; Q3 revs $760.24M vs. est. $510.61M; Q3 Production was 14.3 MMBoe (155.8 MBoe/d) and was 56% oil; the Company is increasing guidance for 2021 production volumes to 49.5-50.0 MMBoe (135.6-137.0 MBoe/d) Financials Hartford Financial (HIG) Q3 core EPS $1.26 vs. est. $0.86; Net income ROE for the trailing 12-month period ended Sept. 30, 2021 was 12.3% and core earnings ROE* for the same period was 12.5%; the Commercial Lines combined ratio was 101.2 in third quarter 2021 with an underlying combined ratio* of 87.2, a 6.5-point improvement YoY LPL Financial (LPLA) Q3 EPS $1.77 vs est. $1.75 on revenue $2.02B vs est. $2.05B; total advisory and brokerage assets $1.13 trillion (+40% YoY), organic net new assets $27B (+10% annualized) in the qtr, $110B over past 12-months (+14% annualized) Riley Financial (RILY) announced a $4 dividend, composed of a $3 special one-time payout and a doubling of its regular quarterly dividend to $1 Healthcare 4D Molecular (FDMT)75M share Secondary priced at $25.00 AirSculpt Technologies (AIRS) 7M share IPO priced at $11.00 Aura Biosciences (AURA) 5M share IPO priced at $14.00 Entrada Therapeutics (TRDA)075M share IPO priced at $20.00 Sonendo (SONX)8M share IPO priced at $12.00 Valneva (VALN)5M share Secondary priced at $39.42 Acadia Healthcare (ACHC) Q3 adj EPS in-line at $0.72; Q3 revs $587.6M vs. est. $590.9M; Q3 same facility revenue increased 7.9% YoY, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.2%; same facility adjusted EBITDA margin was 29.0%; narrowed 2021 revenue to $2.295B-$2.315B vs. est. $2.31B CareDX (CDNA) Q3 adj EPS 7c vs est. 1c on revenue $75.6M vs est. $74M; raised FY21 revenue forecast to $290M-$293M from $280M-$290M DaVita Inc. (DVA) 3Q EPS $2.36 vs est. $2.25 on revs $2.94B, says US dialysis treatments averaged 94,509/day; guides FY adj EPS $8.80-9.15 vs est. $9.19 Dexcom (DXCM) Q3 EPS $0.71 vs. est. $0.63; Q3 revs $650.2M vs. est. $617.82; Based on the strong third quarter results, Dexcom is increasing its guidance for fiscal year 2021 revenue, Non-GAAP gross profit margin, Non-GAAP operating margin, and Adjusted EBITDA margin Gilead Sciences (GILD) 3Q adj EPS $2.65 vs est. $1.75 on revs $7.4B vs est. $6.3B; guides FY total product sales $26-26.3B vs est. $25.14B (sees $21.5B ex Veklury); guides FY adj EPS $7.90-8.10 vs est. $7.19 Nextgen health (NXGN) 2Q adj EPS $0.29 vs est. $0.23 on revs $149.3Mm vs est. $143.4Mm; guides FY revs $584-590Mm vs est. $582.4Mm, sees FY adj EPS $0.90-0.96 vs est. $0.93; says may repurchase up to $60Mm of its outstanding shares through March 2023 PTC Therapeutics (PTCT) Q3 EPS loss ($1.89) vs. est. loss ($1.40); Q3 revs $139M vs. est. $126.44M; raises FY21 rev view for DMD franchise to $400M-$420M from $370M-$390M and narrows R&D and SG&A expenses to $815M-$835M from $825M-$855M. ResMed (RMD) 1Q EPS $1.39 vs est. $1.36 on revs $904Mm vs est. $860.9Mm Seagen (SGEN) Q3 EPS ($1.61) vs est. $(0.58) on revenue $424.1M vs est. $383.1M, total net product sales $366.5M (+37% YoY) Stryker (SYK) Q3 adj EPS $2.20 vs. est. $2.28; Q3 revs $4.16B vs. est. $4.23B; Q3 organic net sales increased 4.5%; raises FY21 adjusted EPS view to $9.08-$9.15 from $8.80-$9.20 (est. $9.30); said now expect 2021 organic net sales growth to be in the range of 7% to 8% from 2019 Industrials & Materials Eastman Chemical (EMN) 3Q adj EPS $2.46 vs est. $2.46 on revs $2.72B vs est. $2.6B; guides FY EPS $8.80-9.00 vs est. $9.09, sees FY FCF about $1.1B; says implementing price increases across specialty product lines to offset higher costs, expect to be caught up in early 2022 Ecolab (ECL) to acquire Purolite, a leading global provider of fast-growing, high value separation and purification solutions to life sciences and critical industrial markets; Ecolab to pay approximately $3.7 billion in cash Fortive (FTV) Q3 adj EPS $0.66 vs. est. $0.65; Q3 revs $1.3B vs. est. $1.32B; raises FY21 adj EPS view to $2.70-$2.75 from $2.65-$2.75 (est. $2.72); said Delivered significant margin improvement, strong adjusted operating margin expansion and robust cash flow growth Hub Group (HUBG) Q3 EPS $1.28 vs est. $1.10 on in-line revs $1.08B; raises FY21 EPS $3.90-$4 from $3.50-$3.70 vs est. $3.66, still sees rev growth in the high-teens Huntington Ingalls (HII) 2Q adj EPS $1.71 vs est. $1.17 on revs $537Mm vs est. $375.6Mm L3Harris Technologies (LHX) raises FY21 adjusted EPS view to $12.85-$13.00 from $12.80-$13.00 and lowers FY21 revenue view to approximately $17.9B from $18.1B-$18.5B Mercer Int’l (MERC) 3Q EPS $1.04 vs est. $0.83 on revs $469.7Mm vs est. $452.9Mm Polymetal International PLC (POLY) 2Q adj EPS $0.77 vs est. $0.56 on revs $419Mm vs est. $428.4Mm; guides FY adj EPS $2.30-2.70 vs est. $3.10, sees FY revs $1.675-1.725B vs est. $1.8B Republic Service (RSG) 3Q adj EPS $1.11 vs est. $1.05 on revs $2.93B vs est. $2.84B; guides FY adj EPS $4.10-4.13 from prior $4.00-$4.05 and vs est. $4.05 Terex Corp. (TEX) 3Q EPS $0.67 vs est. $0.72 on sales $993.8Mm vs est. $1.0B; guides FY sales $3.85B vs est. $3.86B, sees FY EPS $2.75-2.85 vs est. $2.82 Werner Enterprise (WERN) Q3 EPS $0.94 vs. est. $0.95; Q3 revs $702.9M vs. est. $700.8M S. Steel (X) announces a $300 million stock repurchase program and increases its quarterly dividend to $0.05 per share; Q3 adjusted EPS $5.36 tops consensus $4.85; Q3 revs $5.96B vs. est. $5.79B
80 Replies 9 👍 11 🔥
Thursday, October 28, 2021 Futures Up/Down % Last Dow 54.00 0.15% 35,443 S&P 500 11.25 0.26% 4,556 Nasdaq 74.50 0.47% 15.662 U.S. futures are looking at a rebound after a late day swoon erased record gains for stocks, as markets again await another earnings barrage, with yesterday and today the two busiest days of the quarter. Drama out of Washington D.C. also adding to the volatility as investors remain hopeful on a spending bill. As for Wednesday, a midday all-time high for the Nasdaq 100 was marred by a late day sell-off in U.S. stocks, as the S&P 500 and Dow each retreated from records set just the previous day, led by weakness in energy stocks as oil prices tumbled from 7-year highs and long-dated Treasury yields also slumped, with the 30-year falling as much as 10bps below 2%. Corporate earnings have generally been better-than-expected, but constant reminders about rising costs, supply-chain issues, and labor shortages on conference calls brings into question the strength of markets going forward. Couple that with expectations for the Fed to begin its asset tapering plans in November and chances of interest rate hikes in mid-2022 to help prevent inflation getting further out of hand remains a market concern. Shares of Dow components McDonald’s, Coca-Cola and Microsoft rallied behind strong earnings. In fact, the Nasdaq outperformed behind large cap winners (TSLA, GOOGL MSFT, AMZN), though breadth was decisively negative and SmallCaps plunged with the Russell 200 falling nearly 2%. President Biden’s infrastructure and social-spending plans still remain “up-in-the-air” which also adds uncertainty. In Asian markets, The Nikkei Index fell about 1% to 28,820, the Shanghai Index slipped -1.23% to 3.518 and the Hang Seng Index dipped about -0.25% to 25,555. In Europe, the German DAX is down -0.15% at 15,680, while the FTSE 100 is also down roughly -0.2% at 7,240. Market Closing Prices Yesterday The S&P 500 Index dropped -23.11 points, or 0.51%, to 4,551.68 The Dow Jones Industrial Average fell -266.19 points, or 0.74%, to 35,490.69 The Nasdaq Composite little changed, or 0.00%, to 15,235.84 The Russell 2000 Index declined -43.58 points, or 1.90% to 2,252.49 Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 290K 8:30 AM EST Continuing Claims…est. 2.415M 8:30 AM ET Gross Domestic Product (GDP) for Q3-A…est. 2.7% (down from prior) 8:30 AM ET GDP Consumer Spending for Q3-A…prior month 12.0% 8:30 AM ET GDP Price Deflator for Q3…est. 5.5% 8:30 AM ET Core-PCE Prices Advance for Q3…est. 4.5% 10:00 AM ET Pending Home Sales MoM for September…est. 0% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for October 1:00 PM ET U.S. to sell $62 bln 7-year notes Earnings Calendar: Earnings Before the Open: AB, ABMD, ADS, AEP, AGCO, ALNY, AMT, AOS, ATI, BAX, BC, BSIG, BTU, CARR, CAR, CBRE, CBZ, CFR, CG, CMCO, CMCSA, CMS, CNX, COLB, CONE, COOP, COR, CWT, DBD, EME, EXP, FCN, GPI, GVA, HBAN, HSY, IBP, ICE, ITW, KBR, KDP, KEX, LECO, LH, LKQ, MA, MCO, MDD, MO, MRK, NEM, NLSN, NOC, OSK, OSIS, OSTK, PBF, RGEN, RLGY, RS, SAH, SAIA, SNDR, SWI, SWK, TAP, TFX, TPX, TREE, TW, TXT, VC, VLY, WEX, WST, XEL, YUM Earnings After the Close: AAPL, ABCB, ACHC, AGL, AMZN, ASPN, ATEN, ATR, AVT, AX, BIO, BY, CDNA, CHE, COHU, COLM, CPT, CUZ, CWST, DECK, DVA, DXCM, EB, EMN, FISI, FTDR, FTV, GILD, HIG, HUBG, LOPE, LPLA, LTC, NGRC, MHK, MMSI, MPWR, MSTR, NATI, NXGN, PEB, POWI, PSB, PTCT, QUMU, RMD, RSG, SBCF, SBUX, SGEN, SKX, SKYW, SM, SPNE, SSNC, SYK, TEX, TXRH, VCRA, VRSN, WDC, WRAP, WRE, X, ZEN Macro Up/Down Last Nymex -1.61 81.05 Brent -1.37 83.21 Gold -2.10 1,801.20 EUR/USD -0.0006 1.1598 JPY/USD -0.23 113.57 10-Year Note +0.012 1.541% Sector News Breakdown Consumer eBay Inc. (EBAY) 3Q adj EPS $0.90 vs est. $0.89 on revs $2.5B vs est. $2.46B; guides 4Q adj EPS $0.72-0.76 vs est. $1.00, sees 4Q revs $2.57-2.62B vs est. $2.65B; raising estimated FY share buyback from $5.0B to $7.0B Ford Motor (F) announces resumption of stock dividend in 4q; 3Q adj EPS $0.51 vs est. $0.27 on revs $35.7B vs est. $32.5B; expects cash flow over current planning period to be more than sufficient to fund growth, announces resumption of regular stock dividend in 4Q; no changes to FY adj FCF guide of $4.0-5.0B Boot Barn (BOOT) Q2 EPS $1.25 vs est. $0.93 on revenue $312.7M (+67.1% vs 2Q19) vs est. $291M, same-store sales +61.7% YoY, +53.6% vs 2019; sees new unit growth 10% in FY22; named Jim Watkins as CFO with current CFO Greg Hackman continuing as VP and COO Churchill Downs (CHDN) 3Q EPS $1.57 vs est. $1.47 on revs $393Mm vs est. $406.8Mm Fresh Del Monte Produce Inc. (FDP) said it is raising prices on bananas, pineapples and fresh-cut fruit in response to unprecedented market conditions and inflationary pressures being felt across all industries iRobot (IRBT) Q3 EPS $1.67 vs. est. $0.70; Q3 revs $440.7M vs. est. $417.04M; cuts FY21 non-GAAP EPS view to $1.15-$1.74 from $2.25-$3.15 (est. $2.70) and lowers FY21 revenue view to $1.56B-$1.59B from $1.55B-$1.62B (est. $1.58B) Noodles (NDLS) Q3 adj EPS 12c vs est. 9c on in-line revenue $125.1M with digital sales 52% of total revs; system-wide comp sales +16.3% vs est. +14.3%, avg unit volume $1.38M, +16% YoY; now sees 7-9 new restaurants in 2021, down from prior outlook for 10-15; anticipates system-wide unit growth of at least 8% next year O’Reilly Auto (ORLY) Q3 EPS $8.07 vs. est. $7.18; Q3 sales $3.48B vs. est. $3.3B; gross profit margin 52.3% vs. 52.4% y/y; raises year rev outlook to $12.9B-$13.2B from prior $12.3B-$12.6B (est. $12.73B) Sleep Number (SNBR) 3Q EPS $2.22 vs est. $1.44 on revs $640Mm vs est. $587.1Mm; sees FY EPS $7.25 vs est. $7.15; Spirit Airlines (SAVE) Q3 adj EPS ($0.69) was a narrower loss than est. ($1.02) on in-line revs $922.6M; load factor 77.6%, capacity +3.5% vs 3Q19; is slowing the pace to push back to full fleet utilization, expects to produce 53B-55B available seat miles in 2022 VICI Properties (VICI) 3Q adj FFO/shr $0.45 on revs $375.7Mm; guides FY adj FFO/shr $1.7901.80 vs est. $1.84 Wyndham Hotels (WH) 3Q EPS $1.09 vs est. $0.91 on net revs $463Mm vs est. $463Mm; guides FY RevPAR growth about 43%, sees fee-related and other revs $1.21-1.23B; guides FY adj EPS $2.93-3.03 vs est. $2.69 Yum China (YUMC) Q3 adj EPS $0.22 vs. est. $0.31; Q3 revs $2.55B vs. est. $2.51B; qtrly total system sales increased 1% year over year, with increases of 1% at both KFC and Pizza Hut, excluding f/x; increasing gross new stores target to over 1,700 in 2021; expect that covid-19, especially the delta variant outbreaks, will continue to affect consumer behavior and impact our same-store sales recovery. Solo Brands, Inc. (DTC) prices 12.9M share IPO at $17.00 per share Scientific Games Corp (SGMS) announces sale of lottery business to Brookfield business partners for $6.05 billion; deal consisting of $5.825 bln in cash & an earn-out of up to $225 mln based on achievement of certain ebitda targets in 2022 & 2023 Energy, Industrials & Materials Allison Transmission (ALSN) 3Q EPS $0.89 vs est. $0.90 on revs $567Mm vs est. $584Mm; guides FY sales $2.325-2.4B vs est. $2.36B Flowserve Corp. (FLS) 3Q adj EPS $0.29 vs est. $0.40 on revs $866.1Mm vs est. $899Mm; guides FY revs down 2-4% vs est. -2.3%, sees FY EPS $1.45-1.65 (was $1.40-1.45) vs est. $1.58, sees CAPEX $70-80Mm vs prior $65Mm Kraton (KRA) Q3 adj EPS $0.98 vs. est. $0.79; Q3 revs $526.9M vs. est. $459.1M; Polymer segment operating income of $43.8 million, compared to an operating loss of $5.1 million YoY; Chemical segment operating income of $35.7M, compared to an operating loss of $401.7M YoY Sunnova Energy (NOVA) Q3 EPS ($0.25) vs est. ($0.13) on revenue $68.9M vs est. $67.4M; reaffirmed FY21 view for adj EBITDA $80M-$85M, customer additions 55k-58k; set FY22 guidance for adj EBITDA $117M-$137M, customer additions 83k-87k Tronox Holdings (TROX) Q3 adj EPS $0.72 vs. est. $0.64; Q3 revs rose 29% to $870M vs. est. $905.3M United Rentals (URI) 3Q adj EPS $6.58 vs est. $6.80 on revs $2.6B vs est. $2.58B; guides FY revs $9.6-9.75B vs est. $9.6B, sees FY adj EBITDA $4.325-4.4B vs est. 4.3B Financials Aflac (AFL) Q3 adj EPS $1.53 vs. est. $1.32; Q3 revs $5.2B vs. est. $5.34B; in yen terms, Aflac Japan’s net premium income was ¥323.1 bln for quarter, or 4.0% lower than a year ago AvalonBay (AVB) Q3 core FFO $2.06 vs est. 1.97, EPS $0.56 vs est. $0.77, same-store sales +1.2%; sees Q4 core FFO $2.19-$2.29 vs est. $2.11, raised FY core FFO view to $8.18-$8.28 from $7.92-$8.12 CyrusOne Inc. (CONE) 3Q adj FFO/shr $1.02 vs est. $0.99 on revs $304.1Mm vs est. $290.4Mm; guides FY revs $1.18-1.2B vs est. $1.17B Invitation Homes (INVH) Q3 core FFO 38c/shr vs est. 36c, EPS 12c vs est. 10c, revenue $510M vs est. $497.8M; same-store NOI +11.9% YoY on same-store revs +7.9%; raised FY21 core EPS view to $1.49 at midpoint from $1.44, adj FFO ro $1.28 at midpoint from $1.24 Lending Club (LC) Q3 EPS $0.26 vs est. $0.03 on revenue $246.2M vs est. $221.2M; sees Q4 revs $240M-$250M vs est. $235.7M, loan originations $2.8-$3B; raised FY view for revenue to $796M-$806M from $750M-$780M Raymond James (RJF) Q4 EPS $2.06 vs. est. $1.71; Q4 revs $2.7B vs. est. $2.54B; quarter-end records for client assets under administration of $1.18 trillion, financial assets under management of $191.9B, and net loans at Raymond James Bank of $25B The SEC asked at least one asset manager not to proceed with plans for a leveraged bitcoin exchange-traded fund, according to a person familiar with the matter. The SEC indicated it wants to limit new bitcoin-related products to those that provide unleveraged exposure to bitcoin futures contracts, such as the ProShares Bitcoin Strategy exchange-traded fund, which was launched last week, the person said. https://on.wsj.com/3GvG2qg Healthcare Align Technology (ALGN) 3Q adj EPS $2.87 vs est. $2.60 on revs $1.02B vs est. $978Mm; guides FY revs $3.9-3.95B vs est. $3.94B; says clinical study validates benefits of the Itero Element 5D imaging system Alnylam (ALNY) reports positive topline 18-month results from Helios-a phase 3 study of Vutrisiran in patients with HATTR amyloidosis with polyneuropathy BioMarin (BMRN) Q3 GAAP EPS loss (-$0.20) vs. est. loss (-$0.25); Q3 revs $408.7M vs. est. $435.32M; Lower Kuvan product revenues primarily due to generic competition due to the loss of exclusivity in the U.S.; Lower Aldurazyme product revenues due to timing of product fulfillment to Genzyme Edwards LifeSciences (EW) Q3 EPS $0.54 vs. est. $0.53; Q3 revs $1.3B vs. est. $1.32B; sees FY21 adjusted EPS at high end of $2.07-$2.27 (est. $2.26) and reaffirms FY21 revenue view $5.2B-$5.4B (est. $5.32B); TAVR sales grew 15%; underlying 14%; U.S. TAVR sales grew 12%; OUS approximately 20% Encompass Health (EHC) Q3 adj EPS $1.03 vs. est. $1.06; Q3 revs $1.28B vs. est. $1.31B; cuts FY21 adj EPS view to $4.23-$4.38 from $4.32-$4.47 and lowers FY21 revenue view to $5.08B-$5.13B from $5.1B-$5.25B (est. $5.18B) Molina Healthcare (MOH) Q3 adj EPS $2.83 vs. est. $2.79; Q3 revs $7.04B vs. est. $6.79B; backs FY21 EPS view of no less than $13.25 vs. est. $13.38 and backs FY21 revenue view of no less than $27.5B vs. est. $26.97B; consolidated MCR for Q3 was 88.9%, compared to 85.9% in the third quarter of 2020 Teladoc (TDOC) Q3 EPS loss (-$0.53) vs. est. loss (-$0.65); Q3 revs $521.66M vs. est. $516.6M; Q3 visits topped 3.9M, 37% higher than Q3 2020; sees Q4 EPS loss (73c)-(53c) vs. est. loss (69c); sees Q4 revs $536M-$546M vs. est. $539.74M; sees Q4 total visits 3.9M-4.1M
150 Replies 10 👍 8 🔥
Monday, September 27, 2021 Futures Up/Down % Last Dow 91.00 0.26% 34,765 S&P 500 1.25 0.03% 4,447 Nasdaq -48.50 0.32% 15,270 U.S. stock futures are looking higher, led by the energy complex after WTI crude tops $75 for the first time since July and Brent crude hitting 3-year highs following a massive stock market recovery late last week as fears about China Evergrande Group ‘s debt crisis issues waned and investors bet on further economic reopening from the pandemic. Despite the Chinese property developer missing a bond coupon payment, the S&P 500 still finished the week up 0.5% (though U.S. listed China stocks fell sharply on the week). Last week, Federal Reserve Chairman Jerome Powell said the U.S. economy has recovered sufficiently for the central bank to potentially announce the start of bond-purchase tapering at its next meeting, which failed to dent investor optimism, even as Treasury yields and the dollar rallied as the FOMC pushed up its timeline for interest rate hikes. In Asian markets, The Shanghai Composite Index slipped 0.8%, while Hong Kong’s Hang Seng Index edged up 0.1%. The Nikkei Index was down slightly at 30,240, the Shanghai Index dipped -30 points to 3,583 and the Hang Seng Index edged higher 16 points to 24,208. In Europe, the German DAX rises following election results, up around 100-points (0.6%) at 15,625, while the FTSE 100 is up slightly above 7,060. Oil futures rise with WTI crude oil futures topping $75 a barrel for the first time since July, amid an escalating energy crunch across Europe and now China. Energy is the clear premarket leader among the S&P sectors, most of which are higher. Materials and Info Tech are slightly lower. Treasury yields are moving to their best levels since late June, with the benchmark 10-year yield above 1.49% and the 30-year topping 2%, extending last week gains which saw the largest one-week yield gain since June 25, as it rose nearly 8 basis points. The 10-year was yielding 1.495%, up from 1.454%. Markets await data on new U.S. orders for durable goods in August at 8:30 AM ET. Market Closing Prices Yesterday The S&P 500 Index gained 6.50 points, or 0.15%, to 4,455.48 The Dow Jones Industrial Average rose 33.18 points, or 0.10%, to 34,798.00 The Nasdaq Composite slipped -4.54 points, or 0.03%, to 15,047.70 The Russell 2000 Index declined -10.97 points, or 0.49% to 2,248.07 Events Calendar for Today 8:30 AM ET Durable Goods Orders for Aug 8:30 AM ET Durable Goods Ex: Transportation for Aug 10:30 AM ET Dallas Fed Manufacturing for Sept 1:00 PM ET U.S. to sell $61 bln 5-year notes 1:00 PM ET U.S. to sell $60 bln 2-year notes Earnings Calendar: Earnings Before the Open: $AYTU, $IBIO, $SANW Earnings After the Close: $CNXC Other Key Events: BMO Capital Washington DC Property Tour, 9/27-9/28 Cantor Global Healthcare Conference (virtual), 9/27-9/30 Macro Up/Down Last Nymex 1.08 75.06 Brent 1.16 79.25 Gold -1.15 1,749.25 EUR/USD -0.0019 1.1701 JPY/USD 0.22 110.95 10-Year Note +0.03 1.491% World News House Speaker Nancy Pelosi pledged to pass a $550 billion infrastructure bill this week and signaled that the headline amount on a bigger package of spending and tax measures will be lowered from $3.5 trillion German inflation is likely to accelerate from already high levels and will stay above 2% through mid-2022, exceeding the European Central Bank’s target for the 19-nation euro zone, the Bundesbank said in a monthly report on Monday Widening power shortages in China have halted production at numerous factories including many supplying Apple and Tesla. On Monday, State Grid Corp pledged to ensure basic power supply and avoid electricity cuts. China’s power crunch, caused by tight coal supplies and toughening emissions standards, has hurt production in industries across several regions – Dow Jones Sector News Breakdown Consumer Scotts Miracle-Gro ($SMG) mentioned positively in Barron’s saying the co has a dominant franchise in the consumer lawn and garden market, and it has a fast-growing hydroponics business catering mainly to the marijuana industry. Scotts has seen its stock fall over 40% from an April high to a recent $146 on lower consumer demand in 2022 and narrower profit margins concerns but yet the stock looks inexpensive Lordstown Motors ($RIDE) downgraded to Sell from Neutral at Goldman Sachs Tesla’s ($TSLA) Shanghai factory is expected to produce 300,000 cars in the first nine months of the year, despite a global semiconductor shortage, Reuters reported Gores Guggenheim Inc ($GGPI) rises after Swedish electric car maker Polestar agrees to go public through merger with GGPI, at a valuation of $20 bln including debt https://bit.ly/3udy8fD Energy, Industrials and Materials Lockheed Martin ($LMT) was awarded a $1.1B modification to a previously awarded fixed-price incentive advance acquisition contract. Piedmont Lithium ($PLL) files automatic mixed securities shelf BP plc ($BP) says panic buying has caused 30% of its 1,200 gasoline stations in the U.K. to run out of the two main grades of fuel. Healthcare Acceleron Pharma Inc. ($XLRN) is in advanced discussions to be acquired by a large pharmaceutical company for about $180 a share in cash, according to people familiar with the matter, Bloomberg reported late Friday https://bloom.bg/3ANfEVx Pfizer ($PFE), Opko ($OPK) said late Friday the FDA extended the review period for the biologics license application for somatrogon SeaSpine Holdings Corp. ($SPNE) said late Friday it expects its total revenue for q3 of 2021 to grow in mid-single digit range; said it is unable to confirm its prior revenue guidance for q4 and full-year 2021 at this time Syndax Pharmaceuticals ($SNDX) and Incyte ($INCY) announce global collaboration to develop and commercialize axatilimab for chronic graft-versus-host disease and other fibrotic diseases; Syndax to receive $152 million in cash ($117 million upfront plus a $35 million equity investment, with potential for $450 million in additional milestone payments) ASLAN Pharmaceuticals (ASLN) shares fall after announcing data conclusively establishing proof of concept for ASLAN004 in atopic dermatitis; said topline data from multiple-ascending-dose study supports a potentially differentiated safety and efficacy profile. ASLAN004 achieved a statistically significant improvement vs. placebo in the primary efficacy endpoint of percent change from baseline in EASI with significant improvements in other efficacy endpoints Astellas Pharma ($ALPMY) and Seagen ($SGEN) announced that Japan’s Ministry of Health, Labor and Welfare has approved PADCEV (enfortumab vedotin) for radically unresectable urothelial carcinoma that has progressed after anti-cancer chemotherapy. Technology, Media & Telecom Google ($GOOGL), seeking to overturn the EU’s $5B antitrust decision from 2018, is arguing that its Android operating system for mobile devices has boosted competition rather than stifled it – WSJ Several Apple ($AAPL) and Tesla ($TSLA) suppliers have halted production at some of their Chinese facilities to comply with Beijing’s tighter energy consumption policy, putting supply-chain continuity at risk during a peak season for electronics goods including the latest iPhones. – Nikkei reports https://s.nikkei.com/3m1F7EF Vizio ($VZIO) a positive mention in Barron’s saying stock buyers should consider newly public Vizio, which completed upfront advertising negotiations with more than $100 million in commitments, up fourfold from last year com’s ($AMZN) Whole Foods Market is implementing a grocery delivery fee across the U.S., rolling back a perk the retailer had offered for paying Prime members since it began offering home delivery from the organic grocer
61 Replies 15 👍 9 🔥
Next targets are EDIT and SGEN on my board
41 Replies 9 👍 11 🔥
same with SGEN coming soon
136 Replies 7 👍 12 🔥
*POINT72 ADDS AMAT, EXPE, CRM, SGEN, SQ, WAT, IQ, FDX IN 1Q: 13F *POINT72 REDUCES GOOGL, AMD, LVS, AZO, ACGL, JD, MSFT IN 1Q: 13F *POINT72 EXITS LLY, FISV, DIS, IQV, SPGI, BHC, ZS IN 1Q: 13F
49 Replies 10 👍 7 🔥
yo what's up with SGEN?
129 Replies 6 👍 10 🔥
hows the sgen chart look ? i am in it, just trying to figure out, overnight swing or not
147 Replies 6 👍 11 🔥
SGEN think it keeps going? got rejected at 190
100 Replies 6 👍 6 🔥
i will be glad to see those sgen options gone
133 Replies 13 👍 13 🔥
SGEN bustin it. can it hold for the next 4 minutes?
89 Replies 11 👍 10 🔥
see if SGEN can finish strong
68 Replies 7 👍 10 🔥
SGEN bustin a move. trying to get over that 20ma
88 Replies 14 👍 6 🔥
Haha you got this sgen
142 Replies 6 👍 6 🔥
that has as much of a chance as sgen being 250 next week
69 Replies 6 👍 15 🔥
down 450% on SGEN lol
71 Replies 6 👍 12 🔥
the SGEN pricing is soooo messed up
62 Replies 12 👍 13 🔥
anyone mind checking the mar sgen 220/230 vert?
114 Replies 14 👍 13 🔥
yah but maybe just wait now and preserve the capital ... > @dros said: @Jig get a few SGEN you mean?
102 Replies 6 👍 12 🔥
@Jig get a few SGEN you mean?
92 Replies 7 👍 11 🔥
SGEN is presenting at a conference on the 11th
137 Replies 14 👍 14 🔥
yeah SGEN probably expires worthless
57 Replies 8 👍 6 🔥
hopefully sgen gets a buyout in the next 2.5 weeks but Im expecting it to goto 0
131 Replies 12 👍 7 🔥
I have a bunch of cash. no short term options except sgen
92 Replies 13 👍 13 🔥
SGEN really getting sold off now
89 Replies 8 👍 6 🔥
yeah SGEN went from a nice winner to a big loser
115 Replies 13 👍 14 🔥
89 Replies 13 👍 14 🔥
ouch on sgen
131 Replies 9 👍 8 🔥
Nav why would u average sgen on an up day like today?
51 Replies 9 👍 12 🔥
so i know SGEN was kinda spec/m&a. everyone holding until exp?
81 Replies 11 👍 8 🔥
some Sgen Jan 230 flow
53 Replies 9 👍 10 🔥
Next Dividend Date
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union.